Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-10-27 4:23 pm Sale | 13G | ALIMERA SCIENCES INC ALIM | MORGAN STANLEY MS | 563,324 8.1% | -356,222 (-38.74%) | View |
2022-05-25 5:18 pm Purchase | 13D | ALIMERA SCIENCES INC ALIM | Caligan Partners LP | 411,527 5.9% | 411,527 (New Position) | View |
2022-03-10 4:21 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | MORGAN STANLEY MS | 919,546 13.3% | 490,000 (+114.07%) | View |
2022-02-14 5:07 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | Palo Alto Investors LP | 802,423 11.57% | 802,423 (New Position) | View |
2022-02-10 2:33 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | MORGAN STANLEY MS | 429,546 6.2% | 8,834 (+2.10%) | View |
2022-02-03 4:05 pm Sale | 13G | ALIMERA SCIENCES INC ALIM | HIRSCHMAN ORIN | 0 0% | -501,025 (Position Closed) | View |
2021-04-30 1:16 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | Ocumension Therapeutics | 1,144,945 16.62% | 1,144,945 (New Position) | View |
2021-02-16 4:20 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | Palo Alto Investors LP | 802,423 15.64% | 802,423 (New Position) | View |
2021-02-12 12:40 pm Sale | 13G | ALIMERA SCIENCES INC ALIM | Flynn James E | 0 0% | -676,667 (Position Closed) | View |
2021-02-12 08:11 am Sale | 13G | ALIMERA SCIENCES INC ALIM | Avoro Capital Advisors LLC | 0 0% | -415,999 (Position Closed) | View |
2021-02-10 4:18 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | HIRSCHMAN ORIN | 501,025 11% | 28,000 (+5.92%) | View |
2021-02-10 11:28 am Sale | 13G | ALIMERA SCIENCES INC ALIM | MORGAN STANLEY MS | 420,712 8.2% | -26 (-0.01%) | View |
2020-11-09 4:20 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | MORGAN STANLEY MS | 420,738 8.2% | 420,738 (New Position) | View |
2020-09-29 4:44 pm Purchase | 13D | ALIMERA SCIENCES INC ALIM | Domain Partners VI L.P. | 239,394 4.8% | 239,394 (New Position) | View |
2020-08-14 1:01 pm Sale | 13D | ALIMERA SCIENCES INC ALIM | CHEZ RONALD L | 250,299 4.97% | -98,277 (-28.19%) | View |
2020-02-14 2:31 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | ARMISTICE CAPITAL LLC | 228,000 4.6% | 228,000 (New Position) | View |
2020-02-14 1:41 pm Unchanged | 13G | ALIMERA SCIENCES INC ALIM | Palo Alto Investors LP | 802,424 16.16% | 0 (Unchanged) | View |
2020-02-14 10:02 am Purchase | 13G | ALIMERA SCIENCES INC ALIM | Avoro Capital Advisors LLC | 415,999 8.4% | 415,999 (New Position) | View |
2020-02-13 4:37 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | HIRSCHMAN ORIN | 473,025 11% | 473,025 (New Position) | View |
2020-02-13 4:20 pm Unchanged | 13G | ALIMERA SCIENCES INC ALIM | Stonepine Capital Management LLC | 0 0% | 0 (Unchanged) | View |